Literature DB >> 8359576

In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period.

C Thibault1, C Guettet, M C Laury, J M N'Guyen, M A Tormo, D Bailbé, B Portha, L Pénicaud, A Ktorza.   

Abstract

We investigated the importance of the level and the duration of glucose stimulation on the in vivo and in vitro insulin response to glucose in normal rats previously submitted to hyperglycaemia. Rats were made hyperglycaemic by a 48-h glucose infusion. Glucose-induced insulin secretion was investigated in vivo by a 20-min hyperglycaemic clamp and in vitro by the isolated perfused pancreas technique, 3 h after the end of the in vivo glucose infusion. In glucose-infused rats, as compared to controls, in vivo incremental plasma insulin values above baseline integrated over the 20-min hyperglycaemic clamp (delta I) were five times higher during 8 mmol/l glucose clamp, only two times higher in 11 mmol/l glucose clamp and no different in 16.5 mmol/l. Compared to the controls, in vitro incremental plasma insulin concentration above baseline integrated over a 20-min period (delta I) in glucose-infused rats was 16 times higher in response to 2.8 mmol/l glucose, two times higher in response to 5.5 mmol/l, similar in response to 8.3 mmol/l and significantly lower in response to 16.5 mmol/l. In conclusion, our data suggest that a 48-h hyperglycaemic period results in an increased response of the pancreatic beta cell to low glucose. The response is immediately maximal and can not be increased with higher glucose concentrations. This situation could explain the apparent minimal effect of high concentrations on in vitro insulin secretion in previously hyperglycaemic rats and may provide insights into the sequence of events leading to the impairment of beta-cell function in Type 2 (non-insulin-dependent) diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359576     DOI: 10.1007/bf00404066

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Evolution of insulin secretory response to glucose by perifused islets from lean (FA/FA) rats chronically infused with glucose.

Authors:  F J Bedoya; B Jeanrenaud
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

2.  A continuous 48-hour glucose infusion in rats causes both an acute and a persistent redistribution of the blood flow within the pancreas.

Authors:  J Styrud; U J Eriksson; L Jansson
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

3.  Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats.

Authors:  K I Timmers; A M Powell; N R Voyles; D Solomon; S D Wilkins; S Bhathena; L Recant
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

4.  Increased islet blood flow in obese rats: role of the autonomic nervous system.

Authors:  N Atef; A Ktorza; L Picon; L Pénicaud
Journal:  Am J Physiol       Date:  1992-05

Review 5.  Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion.

Authors:  J L Leahy; S Bonner-Weir; G C Weir
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

6.  Hyperglycaemia induced by glucose infusion in the unrestrained pregnant rat during the last three days of gestation: metabolic and hormonal changes in the mother and the fetuses.

Authors:  A Ktorza; J R Girard; M F Kinebanyan; L Picon
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

7.  Adaptation of B and A cell function during prolonged glucose infusion in human subjects.

Authors:  W K Ward; J B Halter; J C Beard; D Porte
Journal:  Am J Physiol       Date:  1984-05

8.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

Authors:  J L Leahy; H E Cooper; D A Deal; G C Weir
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

9.  Stimulation by glucose of the blood flow to the pancreatic islets of the rat.

Authors:  L Jansson; C Hellerström
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

10.  Comparison of insulin secretory patterns in obese nondiabetic LA/N-cp and obese diabetic SHR/N-cp rats. Role of hyperglycemia.

Authors:  L Recant; N R Voyles; K I Timmers; S J Bhathena; D Solomon; S Wilkins; O E Michaelis
Journal:  Diabetes       Date:  1989-06       Impact factor: 9.461

View more
  5 in total

1.  Chronic Glucose Exposure Systematically Shifts the Oscillatory Threshold of Mouse Islets: Experimental Evidence for an Early Intrinsic Mechanism of Compensation for Hyperglycemia.

Authors:  Eric Glynn; Benjamin Thompson; Suryakiran Vadrevu; Shusheng Lu; Robert T Kennedy; Joon Ha; Arthur Sherman; Leslie S Satin
Journal:  Endocrinology       Date:  2015-12-23       Impact factor: 4.736

2.  Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.

Authors:  Z Ling; D G Pipeleers
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

3.  Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells.

Authors:  C Chen; H Hosokawa; L M Bumbalo; J L Leahy
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic beta cell in rats.

Authors:  J M N'Guyen; C Magnan; M C Laury; C Thibault; J Leveteau; M Gilbert; L Pénicaud; A Ktorza
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat.

Authors:  E Zini; M Osto; M Franchini; F Guscetti; M Y Donath; A Perren; R S Heller; P Linscheid; M Bouwman; M Ackermann; T A Lutz; C E Reusch
Journal:  Diabetologia       Date:  2008-11-26       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.